A novel class of antitumour agents. II. In vitro testing. (Record no. 44665)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01179 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250510205705.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199406s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0304-3835 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/s0304-3835(77)80032-3 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Emminger, A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19940609 |
245 00 - TITLE STATEMENT | |
Title | A novel class of antitumour agents. II. In vitro testing. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cancer letters |
Date of publication, distribution, etc. | Mar 1977 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 273-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma 256, Walker |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Screening Assays, Antitumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fibroblasts |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HeLa Cells |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocyte Activation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocytes |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pancuronium |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rats |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kahmann, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Savage, D S |
773 0# - HOST ITEM ENTRY | |
Title | Cancer letters |
Related parts | vol. 2 |
-- | no. 4-5 |
-- | p. 273-8 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/s0304-3835(77)80032-3">https://doi.org/10.1016/s0304-3835(77)80032-3</a> |
Public note | Available from publisher's website |
No items available.